These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 1931606)
1. In vivo 31P nuclear magnetic resonance spectroscopy of experimental murine tumours and human tumour xenografts: effects of blood flow modification. Bremner JC; Counsell CJ; Adams GE; Stratford IJ; Wood PJ; Dunn JF; Radda GK Br J Cancer; 1991 Nov; 64(5):862-6. PubMed ID: 1931606 [TBL] [Abstract][Full Text] [Related]
2. Use of fluorine-19 nuclear magnetic resonance spectroscopy and hydralazine for measuring dynamic changes in blood perfusion volume in tumors in mice. Thomas C; Counsell C; Wood P; Adams GE J Natl Cancer Inst; 1992 Feb; 84(3):174-80. PubMed ID: 1542128 [TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance spectroscopy studies on experimental murine and human tumors: comparison of changes in phosphorus metabolism with induced changes in vascular volume. Adams GE; Bremner JC; Counsell CJ; Stratford IJ; Thomas C; Wood PJ Int J Radiat Oncol Biol Phys; 1992; 22(3):467-71. PubMed ID: 1735680 [TBL] [Abstract][Full Text] [Related]
4. The combined measurement of blood flow and metabolism in RIF-1 tumours in vivo. A study using H2 flow and 31P NMR spectroscopy. Bhujwalla ZM; Tozer GM; Field SB; Proctor E; Busza A; Williams SR NMR Biomed; 1990 Aug; 3(4):178-83. PubMed ID: 2206850 [TBL] [Abstract][Full Text] [Related]
5. Induction of tumour hypoxia by a vasoactive agent. A combined NMR and radiobiological study. Dunn JF; Frostick S; Adams GE; Stratford IJ; Howells N; Hogan G; Radda GK FEBS Lett; 1989 Jun; 249(2):343-7. PubMed ID: 2737292 [TBL] [Abstract][Full Text] [Related]
6. 31P-nuclear magnetic resonance spectroscopy in vivo of six human melanoma xenograft lines: tumour bioenergetic status and blood supply. Lyng H; Olsen DR; Southon TE; Rofstad EK Br J Cancer; 1993 Dec; 68(6):1061-70. PubMed ID: 8260356 [TBL] [Abstract][Full Text] [Related]
7. 31P MRS of tumour metabolism in anaesthetized vs conscious mice. Sansom JM; Wood PJ NMR Biomed; 1994 Jun; 7(4):167-71. PubMed ID: 7946994 [TBL] [Abstract][Full Text] [Related]
8. The effect of hydralazine on blood flow and misonidazole toxicity in human tumour xenografts. Guichard M; Lespinasse F; Trotter M; Durand R; Chaplin D Radiother Oncol; 1991 Feb; 20(2):117-23. PubMed ID: 2031087 [TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance spectroscopic studies on 'real-time' changes in RIF-1 tumour metabolism and blood flow during and after photodynamic therapy. Bremner JC; Bradley JK; Stratford IJ; Adams GE Br J Cancer; 1994 Jun; 69(6):1083-7. PubMed ID: 8198974 [TBL] [Abstract][Full Text] [Related]
10. The energy metabolism of RIF-1 tumours following hydralazine. Bhujwalla ZM; Tozer GM; Field SB; Maxwell RJ; Griffiths JR Radiother Oncol; 1990 Nov; 19(3):281-91. PubMed ID: 2281156 [TBL] [Abstract][Full Text] [Related]
11. Modulation of murine radiation-induced fibrosarcoma-1 tumor metabolism and blood flow in situ via glucose and mannitol administration monitored by 31P and 2H nuclear magnetic resonance spectroscopy. Hwang YC; Kim SG; Evelhoch JL; Seyedsadr M; Ackerman JJ Cancer Res; 1991 Jun; 51(12):3108-18. PubMed ID: 1904001 [TBL] [Abstract][Full Text] [Related]
12. Bioreductive drugs and the selective induction of tumour hypoxia. Bremner JC; Stratford IJ; Bowler J; Adams GE Br J Cancer; 1990 May; 61(5):717-21. PubMed ID: 2110814 [TBL] [Abstract][Full Text] [Related]
13. Reduced blood flow increases the in vivo ammonium ion concentration in the RIF-1 tumor. Constantinidis I; Gamcsik MP Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):143-9. PubMed ID: 7642412 [TBL] [Abstract][Full Text] [Related]
14. Effect of hydralazine in spontaneous tumours assessed by oxygen electrodes and 31P-magnetic resonance spectroscopy. Nordsmark M; Maxwell RJ; Wood PJ; Stratford IJ; Adams GE; Overgaard J; Horsman MR Br J Cancer Suppl; 1996 Jul; 27():S232-5. PubMed ID: 8763887 [TBL] [Abstract][Full Text] [Related]
15. Glucose metabolism in RIF-1 tumors after reduction in blood flow: an in vivo 13C and 31P NMR study. Bhujwalla ZM; Shungu DC; Chatham JC; Wehrle JP; Glickson JD Magn Reson Med; 1994 Sep; 32(3):303-9. PubMed ID: 7984062 [TBL] [Abstract][Full Text] [Related]
16. Monitoring metabolic responses after induction of hypoxia in the KHT tumour using 31P NMR spectroscopy. Bremner JC; Counsell CJ; Edwards HS; Stratford IJ; Adams GE; Nethersell AB; Bedford P Int J Radiat Biol; 1991; 60(1-2):363-7. PubMed ID: 1677995 [No Abstract] [Full Text] [Related]
17. Differences in vascular response between primary and transplanted tumours. Field SB; Needham S; Burney IA; Maxwell RJ; Coggle JE; Griffiths JR Br J Cancer; 1991 May; 63(5):723-6. PubMed ID: 1645562 [TBL] [Abstract][Full Text] [Related]
18. 31P-magnetic resonance spectroscopy and 2H-magnetic resonance imaging studies of a panel of early-generation transplanted murine tumour models. Robinson SP; van den Boogaart A; Maxwell RJ; Griffiths JR; Hamilton E; Waterton JC Br J Cancer; 1998 Jun; 77(11):1752-60. PubMed ID: 9667643 [TBL] [Abstract][Full Text] [Related]
19. [Use of fluorine-19 nuclear resonance spectroscopy for the measurement of changes induced in blood perfusion volume in experimental tumors in vivo]. Thomas C; Counsell C; Wood P; Adams G Bull Cancer; 1993 Aug; 80(8):666-73. PubMed ID: 7515732 [TBL] [Abstract][Full Text] [Related]
20. The accuracy and reproducibility of measuring blood flow in murine tumours by the D2O uptake and clearance techniques. Bradley JK; Counsell CJ; Bremner JC; Sansom JM; Adams GE NMR Biomed; 1994 May; 7(3):141-8. PubMed ID: 8080716 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]